[go: up one dir, main page]

IT1291932B1 - ANTI-TUMOR PHARMACEUTICAL COMPOSITIONS ALSO CAPABLE OF REDUCING DRUG RESISTANCE IN CANCER CELLS, PARTICULARLY CARCINOMAS - Google Patents

ANTI-TUMOR PHARMACEUTICAL COMPOSITIONS ALSO CAPABLE OF REDUCING DRUG RESISTANCE IN CANCER CELLS, PARTICULARLY CARCINOMAS

Info

Publication number
IT1291932B1
IT1291932B1 IT97RM000368A ITRM970368A IT1291932B1 IT 1291932 B1 IT1291932 B1 IT 1291932B1 IT 97RM000368 A IT97RM000368 A IT 97RM000368A IT RM970368 A ITRM970368 A IT RM970368A IT 1291932 B1 IT1291932 B1 IT 1291932B1
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
cancer cells
drug resistance
reducing drug
tumor pharmaceutical
Prior art date
Application number
IT97RM000368A
Other languages
Italian (it)
Inventor
Gennaro Ciliberto
Carlo Toniatti
Rocco Savino
Nicolo' Borsellino
Alessandro Natale D
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Priority to IT97RM000368A priority Critical patent/IT1291932B1/en
Publication of ITRM970368A0 publication Critical patent/ITRM970368A0/it
Priority to AU79315/98A priority patent/AU7931598A/en
Priority to PCT/IT1998/000169 priority patent/WO1998058674A1/en
Publication of ITRM970368A1 publication Critical patent/ITRM970368A1/en
Application granted granted Critical
Publication of IT1291932B1 publication Critical patent/IT1291932B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT97RM000368A 1997-06-20 1997-06-20 ANTI-TUMOR PHARMACEUTICAL COMPOSITIONS ALSO CAPABLE OF REDUCING DRUG RESISTANCE IN CANCER CELLS, PARTICULARLY CARCINOMAS IT1291932B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT97RM000368A IT1291932B1 (en) 1997-06-20 1997-06-20 ANTI-TUMOR PHARMACEUTICAL COMPOSITIONS ALSO CAPABLE OF REDUCING DRUG RESISTANCE IN CANCER CELLS, PARTICULARLY CARCINOMAS
AU79315/98A AU7931598A (en) 1997-06-20 1998-06-19 Anti-tumour pharmaceutical compositions capable of reducing drug resistance in tumour cells
PCT/IT1998/000169 WO1998058674A1 (en) 1997-06-20 1998-06-19 Anti-tumour pharmaceutical compositions capable of reducing drug resistance in tumour cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000368A IT1291932B1 (en) 1997-06-20 1997-06-20 ANTI-TUMOR PHARMACEUTICAL COMPOSITIONS ALSO CAPABLE OF REDUCING DRUG RESISTANCE IN CANCER CELLS, PARTICULARLY CARCINOMAS

Publications (3)

Publication Number Publication Date
ITRM970368A0 ITRM970368A0 (en) 1997-06-20
ITRM970368A1 ITRM970368A1 (en) 1998-12-20
IT1291932B1 true IT1291932B1 (en) 1999-01-21

Family

ID=11405133

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97RM000368A IT1291932B1 (en) 1997-06-20 1997-06-20 ANTI-TUMOR PHARMACEUTICAL COMPOSITIONS ALSO CAPABLE OF REDUCING DRUG RESISTANCE IN CANCER CELLS, PARTICULARLY CARCINOMAS

Country Status (3)

Country Link
AU (1) AU7931598A (en)
IT (1) IT1291932B1 (en)
WO (1) WO1998058674A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161673A0 (en) * 2004-04-29 2004-09-27 Applied Research Systems Compositions and methods for therapy of chemotherapy-induced neuropathy
ITRM20050103A1 (en) * 2005-03-10 2006-09-11 Rocco Savino ASSOCIATION OF ANTAGONISTS OF THE INTERLEUCHINE 6 AND ANTIPROLIFERATIVE DRUGS.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69525971T3 (en) * 1994-12-29 2013-01-10 Chugai Seiyaku K.K. USE OF A PM-1 ANTIBODY OR AN MH 166 ANTIBODY FOR REINFORCING THE ANTI-TUMOR EFFECT OF CISPLATINE OR CARBOPLATIN
IT1276555B1 (en) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio HUMAN INTERLUCHINA-6 ANTAGONISTS COMPLETELY UNABLE TO FORM A BOND WITH GP 130, AND USE THEM FOR THE PREPARATION OF COMPOSITIONS
KR19990022359A (en) * 1995-06-07 1999-03-25 다니엘 엘. 캐시앙, 헨리 엘. 노르호프 Oligonucleotides Specific for Cytokine Signal Transducer gｐ130 mRNA

Also Published As

Publication number Publication date
ITRM970368A1 (en) 1998-12-20
AU7931598A (en) 1999-01-04
WO1998058674A1 (en) 1998-12-30
ITRM970368A0 (en) 1997-06-20

Similar Documents

Publication Publication Date Title
IL127056A (en) Aryl pyrimidine derivatives, their preparation and pharmaceutical compositions comprising them
HUP0103513A3 (en) Novel amidine derivatives their preparation and application as medicines and pharmaceutical compositions containing same
ATE230611T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PLASMA PROTEINS
NO20002359L (en) Adenosine derivatives and pharmaceutical composition containing the derivatives
DE3685170D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING HISTAMINE DERIVATIVES.
ATE202472T1 (en) MEDICINAL PRODUCTS CONTAINING OXALIPLATIN
HUP0102372A3 (en) Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same
FI973039A0 (en) New farnecyltransferase inhibitors, their preparation, and these containing pharmaceutical compositions
DE69924999D1 (en) LIPASEHEMMER CONTAINING PHARMACEUTICAL COMPOSITIONS
IL81924A (en) Quinazolinone derivatives,their preparation and antitumor pharmaceutical compositions containing them
ATE279193T1 (en) PHARMACEUTICAL PREPARATION OF MOXIFLOXACIN
DE69814091D1 (en) PRE-ICONAZOLE CONTAINING PHARMACEUTICAL PREPARATIONS
IT1308059B1 (en) SUPPORT OF COMPOSITE SUBSTRATE, IN PARTICULAR OF SLICES OR DISCS
EE9900179A (en) Use of conjugates in prostate cancer drugs
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
DE69900561D1 (en) Pharmaceutical compositions containing mupirocin
AU1453301A (en) Methods of reversing drug resistance in cancer cells
ATE300297T1 (en) COVERED TABLET CONTAINING TRIMEBUTIN MALEATE
IT1291932B1 (en) ANTI-TUMOR PHARMACEUTICAL COMPOSITIONS ALSO CAPABLE OF REDUCING DRUG RESISTANCE IN CANCER CELLS, PARTICULARLY CARCINOMAS
ATE260094T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING MICRONIZED BICYCLIC DRUGS
ITFI990254A0 (en) DIAGNOSTIC METHOD FOR THE RECOGNITION OF NORMAL AND LEUKEMIC MYELOID CELLS, LIGNADS USED IN SAID METHOD AND FORMULATIONS FOR USE
IT1298731B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN
FR2779429B1 (en) OXINDOLE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS
DE69906934D1 (en) PHARMACEUTICAL PREPARATIONS
FR2760457B1 (en) NEW DIPHOSPHINES OF 6,6'-BIS-(1-PHOSPHANORBORNADIENE), THEIR PREPARATION AND THEIR APPLICATIONS

Legal Events

Date Code Title Description
0001 Granted